- Home
- Solutions
- Outcome Measures
- Clinical Outcome Assessments
Clinical Outcome Assessments
A market leading position on COAs
Improving patients’ quality of life by facilitating access to patient-centred outcomes and clinical outcome assessments
-
6,000+
COAs documented -
45,000+
COA translations -
800+
Exclusive distributions of COAs
ICON is the primary sponsor of Mapi Research Trust, a non-profit organisation dedicated to improving patients’ quality of life by facilitating access to clinical outcome assessments (COAs) for the entire scientific community.
Incorporating the patient's voice into new treatments
Mapi Research Trust promotes scientific approaches in the COA field and encourages exchanges between academics, pharmaceutical companies, and international organisations around the world in the service of incorporating the patient’s voice into every step of the development process of new treatments.
Comprehensive expertise at each step of the patient-centric endpoint strategy
With the web-based platform ePROVIDE™ that includes the databases PROQOLID™, PROLABELS™ and PROINSIGHT™, Mapi Research Trust helps academic researchers, healthcare organisations and pharma companies build succesful patient-centric endpoint strategies.
In addition to the databases, the COA management service team answers all requests regarding patient-centred endpoint intelligence, licensing, scoring guides and manuals, translations and eCOA-related services.
The pre-eminent source of information on clinical outcome assessments
For nearly three decades Mapi Research Trust has been a direct contributor to nearly every translational science research program incorporating clinical outcome assessments. The Trust offers free and subsidised access to thousands of independent and academic research programs in over 130 countries every year. Mapi Research Trust contributes 4M€ a year in services that support academic research focusing on the improvement of patients’ lives.
Mapi Research Trust is the pre-eminent source of information on COAs and the most trusted name in the distribution of COA instruments worldwide:
- More than 6,000 COAs described in the PROQOLID™ COA database
- Directly distributes over 800 questionnaires on behalf of their developers/copyright holders
- More than 45,000 COA translations
- Over 200+ languages supported
Digitizing COAs: A streamlined approach to approval
In all aspects of life, paper copies are giving way to electronic versions of documents. Clinical research is no exception as there is an ongoing push to capture trial data electronically to improve both the participant experience and data quality. Download the whitepaper to discover success factors in converting from paper to digital.
The COA licensing process: How to prepare for success
The prerequisites for controlled use of Clinical Outcome Assessments (COAs) and suggestions for streamlining the licensing process, which can be complex and typically involves multiple parties, are detailed in this whitepaper.
Learn more
Request an ePROVIDE platform demo or arrange a meeting
In this section
- Asset Development Consulting
-
Blended Solutions
-
Cardiac Safety Solutions
-
Clinical & Scientific Operations
- Biostatistics
-
Case studies
- Clinical Operations
-
Clinical Supplies Management
- COVID-19
- Clinical data science
-
Endpoint Adjudication Services
- Global Logistics
- Interactive Response Technology
- Investigator Payments
-
Medical Affairs
-
Medical Call Centre Services
-
Medical Writing & Publishing
- Pharmacovigilance
-
Project and Program Management
-
Site Identification and Feasibility
- Commercial Positioning
- Decentralised Clinical Trials
- Early Clinical
- Language Services
-
Laboratories
- Medical Imaging
- Outcome Measures
- Real World Intelligence
- Regulatory Affairs
- Symphony Health data
- Site & Patient Solutions
- Strategic Solutions
-
Technologies